Evidence map›Paper›PMID 42513849›Full record

ReviewMaterials (Basel, Switzerland)2026

Polyhydroxybutyrate (PHB): Production, Properties, Modification Strategies, Additive Manufacturing, Biodegradation, and Applications.

Bairavi Sanjeevi, Duncan E Cree

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Bairavi SanjeeviDepartment of Mechanical Engineering, McMaster University, Hamilton, ON L8S 4L7, Canada.ORCID 0009-0004-3792-276X
Duncan E CreeDepartment of Mechanical Engineering, McMaster University, Hamilton, ON L8S 4L7, Canada.ORCID 0000-0002-5762-0388

Funding

National Sciences and Engineering Research Council of Canada (NSERC) RGPIN-2025-05989
6 · The paper itself

Abstract

Growing environmental concerns over petroleum-based plastics have increased interest in sustainable and biodegradable alternatives such as polyhydroxybutyrate (PHB). PHB is a naturally produced biopolymer synthesized by microorganisms and is widely recognized for its biodegradability, biocompatibility, renewability, and thermoplastic properties. Despite these advantages, PHB use remains limited by brittleness, high crystallinity, low thermal stability, a narrow processing window, and high production costs. This review discusses the production, properties, biodegradation behavior, and applications of PHB, with a focus on strategies to improve its performance. Modification approaches, including copolymerization, polymer blending, filler reinforcement, plasticization, and hybrid composite formulation, are critically reviewed to evaluate their effects on the thermal, mechanical, and processing behavior of PHB-based materials. The review also highlights recent developments in additive manufacturing, particularly fused deposition modeling/fused filament fabrication (FDM/FFF) for the extrusion of biodegradable PHB composite filaments. In addition, the biodegradation of PHB under various environmental conditions, including soil, compost, freshwater, marine, aerobic, and anaerobic environments, are discussed. Current challenges, research gaps, commercialization barriers, and future opportunities related to sustainable feedstocks, advanced composites, additive manufacturing, and circular economy integration are addressed. Overall, PHB shows strong potential as a sustainable alternative for packaging, biomedical, agricultural, and three-dimensional (3D) printing applications.

Indexed as

additive manufacturingbiodegradable polymersbiodegradationbioplasticsfused deposition modeling (FDM)polyhydroxyalkanoates (PHAs)polyhydroxybutyrate (PHB)polymer composites

Identifiers

PMID42513849
PMCPMC13413960

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.